Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05964452 · ClinicalTrials.gov registry record
Efficacy of Methimazole Dosing Algorithm
A clinical trial, sponsored by Cook County Health.
- Terminated
- Registry status
- 11
- Enrollment target
NCT05964452: Clinical Trial study, sponsored by Cook County Health.
NCT05964452 is a clinical trial that was terminated before completion, run by Cook County Health. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05964452 was terminated before completion, sponsored by Cook County Health.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.
Primary Outcome
The proportion of patients achieving euthyroid state during the study period
Interventions
- DRUG Methimazole Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2024-09-17 |
Why NCT05964452 stopped before completion
NCT05964452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Methimazole Tablets is the first listed.
NCT05964452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05964452 about?
NCT05964452 is a clinical study titled "Efficacy of Methimazole Dosing Algorithm". To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.
What is the current status of trial NCT05964452?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2022-02-14. Estimated completion is 2024-09-17.
What interventions are being tested in trial NCT05964452?
The interventions under investigation include: Methimazole Tablets (DRUG).
Who is sponsoring clinical trial NCT05964452?
This trial is sponsored by Cook County Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI